{"transactions":[{"id":952488,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T19:30:55.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":234000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":234000,"derivative":{"exercise_price":1.84,"expiration_date":"2036-01-02","underlying":"Voting Common Stock","underlying_shares":234000},"source":{"system":"sec-edgar","filing":"0001213900-26-001385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390026001385/ownership.xml","form_type":"4"}},{"id":1033313,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2025-09-24T16:01:19.000Z","date":"2025-09-22","kind":"purchase","planned":false,"acquired":true,"shares":41000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant."}],"balance_after":41000,"derivative":{"exercise_price":2.92,"exercise_date":"2026-03-22","expiration_date":"2030-03-22","underlying":"Voting Common Stock","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001213900-25-091099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390025091099/ownership.xml","form_type":"4"}},{"id":1033312,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Voting Common Stock","published_at":"2025-09-24T16:01:19.000Z","date":"2025-09-22","kind":"purchase","planned":false,"acquired":true,"shares":41000,"price":2.43,"value":99630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant."}],"balance_after":74118,"source":{"system":"sec-edgar","filing":"0001213900-25-091099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390025091099/ownership.xml","form_type":"4"}},{"id":1120060,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T06:30:06.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":234000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":234000,"derivative":{"exercise_price":6,"expiration_date":"2035-06-04","underlying":"Voting Common Stock","underlying_shares":234000},"source":{"system":"sec-edgar","filing":"0001213900-25-051729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390025051729/ownership.xml","form_type":"4"}},{"id":1264486,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T17:30:52.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":130000,"derivative":{"exercise_price":6.2,"expiration_date":"2035-02-13","underlying":"Voting Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001213900-25-014950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390025014950/ownership.xml","form_type":"4"}},{"id":1482396,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Performance Restricted Stock Units","published_at":"2024-06-12T16:09:26.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a grant of performance-based restricted stock units (\"PRSUs\"), with each PRSU representing a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"If, by June 10, 2026, the closing price of the Issuer's common stock on the Nasdaq Capital Market is at or above $35.00 per share (subject to adjustment for recapitalizations, stock splits and similar transactions) for thirty consecutive calendar days, all of the shares of the Issuer's common stock subject to the PRSUs shall vest in full on such thirtieth day, so long as the Reporting Person provides continuous services to the Issuer on and through the vesting date, inclusive."}],"balance_after":20000,"derivative":{"expiration_date":"2026-06-10","underlying":"Voting Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-24-052087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390024052087/ownership.xml","form_type":"4"}},{"id":1482395,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T16:09:26.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on June 10, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":10000,"derivative":{"exercise_price":23.95,"expiration_date":"2034-06-10","underlying":"Voting Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-24-052087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390024052087/ownership.xml","form_type":"4"}},{"id":1634465,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-20T19:33:18.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 15, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":100000,"derivative":{"exercise_price":17.95,"expiration_date":"2034-02-15","underlying":"Voting Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-24-015465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390024015465/ownership.xml","form_type":"4"}},{"id":1760677,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Director"}}],"security":"Voting Common Stock","published_at":"2023-10-13T18:57:41.000Z","date":"2023-10-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":87531,"price":0.85,"value":74401.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units."}],"balance_after":331188,"source":{"system":"sec-edgar","filing":"0001013762-23-003902","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000101376223003902/ownership.xml","form_type":"4"}},{"id":1919736,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Voting Common Stock","published_at":"2023-04-14T16:17:37.000Z","date":"2023-04-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":87531,"price":1.46,"value":127795.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units."}],"balance_after":418719,"source":{"system":"sec-edgar","filing":"0001213900-23-029896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390023029896/ownership.xml","form_type":"4"}},{"id":1944861,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-20T17:59:47.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on March 3, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":500000,"derivative":{"exercise_price":1.87,"expiration_date":"2033-03-17","underlying":"Voting Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-23-021493","document":"marketforms-60958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390023021493/marketforms-60958.xml","form_type":"4"}},{"id":2033548,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Director"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-03T16:13:55.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":1093831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 2, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":1093831,"derivative":{"exercise_price":1.78,"expiration_date":"2033-02-02","underlying":"Voting Common Stock","underlying_shares":1093831},"source":{"system":"sec-edgar","filing":"0001213900-23-007992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390023007992/ownership.xml","form_type":"4"}},{"id":2137791,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Voting Common Stock","published_at":"2022-10-13T20:08:55.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":506250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":506250,"source":{"system":"sec-edgar","filing":"0001213900-22-063949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390022063949/ownership.xml","form_type":"4"}},{"id":2320258,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-23T18:06:16.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":1704328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on March 15, 2023, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":1704328,"derivative":{"exercise_price":3.54,"expiration_date":"2032-03-21","underlying":"Common Stock","underlying_shares":1704328},"source":{"system":"sec-edgar","filing":"0001213900-22-014572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177079/000121390022014572/ownership.xml","form_type":"4"}},{"id":4479509,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":70393,"kind":"person","name":"MARTELL RON","position":1,"cik":"0001177079","reported_name":"MARTELL RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-27T22:46:09.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person received a non-qualified stock option granted under the Issuer's 2014 Equity Incentive Plan.  The exercise price per share to be paid by the reporting person at the time the option is exercised is the closing sale price of the Issuer's Common Stock on the NASDAQ Stock Market as of the date of the grant.  The closing sale price on the date of the grant was $1.56."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the option shares shall vest on January 26, 2018 with the remaining fifty percent (50%) of the option shares vesting on January 26, 2019."}],"balance_after":50000,"derivative":{"exercise_price":1.56,"expiration_date":"2027-01-26","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-005970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919117005970/doc4.xml","form_type":"4"}}]}